In this week's episode, we talk about how targeting a specific immune cell called an eosinophil may help lower the burden of COPD (chronic obstructive pilmonary disease). We explore the epidemiology, pathophysiology, and treatment options for COPD, including targeting the eosinophil pathway.
References:
Bhatti, M. S. (1999). A historical look at chlorofluorocarbon refrigerants. ASHRAE Transactions, 105, 1186. https://www.osti.gov/biblio/20002388
Narendra, D. K., & Hanania, N. A. (2019). Targeting IL-5 in COPD. International journal of chronic obstructive pulmonary disease, 1045-1051. https://www.tandfonline.com/doi/full/10.2147/COPD.S155306
World Health Organization. (6 November, 2024). Chronic obstructive pulmonary disease (COPD). [Website, accessed 4 November, 2025]. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
Barnes, P. J. (2019). Inflammatory endotypes in COPD. Allergy, 74(7), 1249-1256. https://onlinelibrary.wiley.com/doi/full/10.1111/all.13760
Dixon F. J. (Ed.). (1987). Advances in immunology (Vol. 39). Academic Press. https://www.google.com/books/edition/Advances_in_Immunology/GXpByqkfZNcC
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
